Search
Patexia Research
Case number 1:20-cv-01581

Otsuka Pharmaceutical Co., Ltd. et al v. Aurobindo Pharma Ltd. et al > Documents

Date Field Doc. No.Description (Pages)
Dec 6, 2021 11 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.)
Dec 6, 2021 12 Notice (Other) (2)
Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth)
Oct 26, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (10 in 1:20-cv-01581-LPS, 377 in 1:19-cv-01938-LPS) STIPULATION and Order Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Aurobindo) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/26/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01581-LPS (ntl)
Oct 26, 2021 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl)
Oct 20, 2021 10 Stipulation (4)
Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Aurobindo), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Feb 10, 2021 8 Answer to Complaint (14)
Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth)
Feb 10, 2021 9 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth)
Jan 14, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd)
Jan 5, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl)
Dec 31, 2020 7 Motion for Leave to Appear Pro Hac Vice (17)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew)
Nov 25, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
Nov 24, 2020 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (mal)
Nov 23, 2020 1 Main Document (11)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3350143.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(mal)
Nov 23, 2020 1 Exhibit A-B (60)
Nov 23, 2020 1 Civil Cover Sheet (5)
Nov 23, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
Nov 23, 2020 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/12/2020. Date of Expiration of Patent: 04/12/2026; pending Patent Term Extension request, when granted, extends to 12/23/2028.Thirty Month Stay Deadline: 1/10/2023. (mal)
Nov 23, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (mal)
Nov 23, 2020 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd.. (mal)
Nov 23, 2020 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (mal)
Nov 23, 2020 1 Complaint* (1)
Menu